News &
Publications

Contacts

Lisa Bailey
Interim Director of Communications
Director of Social Networking
215-214-3954
215-872-5846 (cell phone)
Lisa.Bailey@fccc.edu

Diana Quattrone
Director of Media Relations
215-728-7784
215-815-7828 (cell phone)
Diana.Quattrone@fccc.edu

Communications Staff

 

News

Fox Chase's Ovarian Cancer Risk-Reducing Surgery Resource Translated into Japanese

PHILADELPHIA (December 12, 2008) — The Margaret Dyson Family Risk Assessment Program at Fox Chase Cancer Center, with support from the Sandy Rollman Ovarian Cancer Foundation, was the first in the United States to publish a resource book that presents all the information women need as they consider risk-reducing surgery for ovarian cancer.  Now, in response to a presentation on the book that took place at the 2007 International Society of Nurses in Genetics conference in England, the resource is available in Japanese and is being circulated on the web in Japan.

The book, titled Ovarian Cancer Risk-Reducing Surgery: A Decision-Making Resource, is a comprehensive educational resource for women considering removal of their ovaries for cancer prevention (known as prophylactic oophorectomy).

Women who consider having their ovaries removed are typically at high risk because of family history.  Some of these women have an inherited predisposition to cancer, identified through genetic testing.

Although ovarian cancer is curable in its earliest stages, with surgery alone or surgery plus a combination of drugs developed at Fox Chase, most ovarian cancers are diagnosed later because they produce few symptoms.

Early detection of ovarian cancer is challenging due to inadequate screening tests.  Tests currently available — such as pelvic exams, intravaginal ultrasound and a blood test for a protein called CA-125 — do not reliably find signs of ovarian cancer and may either miss a cancer or falsely indicate one, leading to many unnecessary biopsies.  Consequently, many high-risk women consider having healthy ovaries removed to reduce the risk of cancer developing in the first place.
The book is available free of charge by sending an e-mail to surgerybook@fccc.edu.


Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach.  For more information, call 1-888-FOX CHASE or (1-888-369-2427).

Media inquiries only, please contact Diana Quattrone at 215-728-7784.

More 2008 News Releases »